PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328965
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328965
The Latin American Dental Implants and Final Abutments Market achieved a remarkable value of over $387 million in 2022. The forecast period anticipates an astonishing CAGR of 12.6%, driving the market to reach an impressive $892 million. The market is currently dominated by three leading competitors: Straumann Group, S.I.N., and BioHorizons.
Our medical market research thoroughly examined over 35 dental implant companies across Latin America. Through our comprehensive methodology, we gained insights into market sizes, unit sales, company market shares, and produced accurate forecasts. The full report suite on the Latin American market for dental implants and final abutments encompasses dental implants, final abutments, instrument kits, treatment planning software, and surgical guides.
Market expansion in Latin America will be driven by several factors, including the rising acceptance of advanced technologies and improved training courses in implantology. As more general practitioners receive training in implantology techniques, like using treatment planning software for implant placement and computer-guided surgery, the need for specialization will decrease. Companies invest in training programs to familiarize dentists with their products, thereby enhancing brand awareness and loyalty. Established market players enjoy a crucial advantage by investing more significantly in such training initiatives. As dentists increasingly consider implantology as a viable option for their patients, the dental implant market is poised to grow.
A prevailing pattern in the dental implant industry within cost-sensitive environments like Latin America is the prevalence of off-label sales. These dental implants are labeled as generic and attempt to imitate premium products, such as those provided by Straumann Group, by claiming to be bioequivalent. Such unauthorized transactions persist regularly due to the substantial motivation for cost-saving in Latin America's delicate economy.
In 2022, Straumann Group emerged as the dominant player in the dental implant and final abutment market. Renowned for its top-quality dental implants, Straumann excelled in the premium implant segment, solidifying its leading position. The subsidiary, Neodent, played a pivotal role in the company's success in Latin America, particularly in the value implant segment. Straumann's strategic focus on mergers and acquisitions further reinforced its market leadership. Following closely, S.I.N. Implant System ranked as the second-leading competitor and is on the verge of being acquired by Henry Schein, marking their entry into the Brazilian market. S.I.N. is renowned for its competitively-priced dental implants and expanded its distribution globally. BioHorizons held the third-leading position, achieving growth through its innovative regenerative products complementing dental implants, bolstering their competitive advantage.
List of Charts
List of Figures